Target intelligence / Profile preview

Beta-tubulin taxane binding site

Molecular classification
Cytoskeletal protein, Tubulin, Microtubule-stabilizing agent target
01

Overview

Microtubules are essential cytoskeletal components formed by the polymerization of alpha- and beta-tubulin heterodimers, playing critical roles in cell division, intracellular transport, and structural maintenance [7, 11]. The taxane binding site is a distinct hydrophobic pocket located on the luminal surface of the beta-tubulin subunit, specifically near the M-loop which is involved in lateral protofilament contacts [6, 12, 18]. Drugs such as paclitaxel and docetaxel bind to this site to promote tubulin assembly and stabilize the microtubule lattice against depolymerization [8, 10]. This stabilization suppresses the dynamic instability of microtubules, effectively freezing the mitotic spindle and causing cell cycle arrest at the metaphase-anaphase transition [7, 14]. The resulting mitotic catastrophe triggers programmed cell death (apoptosis), making this site a cornerstone target in the treatment of various malignancies, including breast, lung, and ovarian cancers [9, 15]. However, clinical utility is often challenged by the emergence of resistance mechanisms, such as the overexpression of the beta-III tubulin isoform (TUBB3) or drug efflux transporters like P-glycoprotein [1, 4, 9].

Other names
Taxane binding siteTaxol binding siteTaxoid binding sitePaclitaxel binding siteMicrotubule taxane site
02

Mechanism of action

Binds to the taxane site on the beta-tubulin subunit of the microtubule, promoting tubulin polymerization and stabilizing existing microtubules against depolymerization, which suppresses dynamic instability and leads to mitotic arrest and apoptosis.

03

Biological functions

Cell divisionMitosisIntracellular transportCell shape maintenanceAngiogenesis regulation
04

Disease associations

CancerBreast cancerOvarian cancerNon-small cell lung cancerProstate cancerGastric cancer
05

Safety considerations

Peripheral neuropathyNeutropeniaMyelosuppressionHypersensitivity reactionsAlopecia
06

Interacting drugs

Paclitaxel

6 more in the full profile.

07

Biomarkers

Class III beta-tubulin (TUBB3)Tau proteinMicrotubule-associated protein 4 (MAP4)Stathmin

Beyond the preview

Go deeper on Beta-tubulin taxane binding site.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-tubulin taxane binding site.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call